Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis in Canada.
Anubhav GargEdward MargolinJonathan A MicieliPublished in: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques (2020)
MOG-IgG ON in Canada has a variable presentation with most patients having substantial initial vision loss with good recovery. This is the largest characterization of the disease in Canada to date.